Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9447401 PH20 polypeptide variants, formulations and uses thereof

Patent 9447401 was granted and assigned to Halozyme, Inc. on September, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Robert James Connor0

Ge Wei0

H. Michael Shepard0

Qiping Zhao0

Date of Patent

September 20, 2016

0

Patent Application Number

136947310

Date Filed

December 28, 2012

0

Patent Citations Received

US Patent 12110520 PH20 polypeptide variants, formulations and uses thereof

0

US Patent 12104185 PH20 polypeptide variants, formulations and uses thereof

0

US Patent 11952600 PH20 polypeptide variants, formulations and uses thereof

0

US Patent 12018298 PH20 polypeptide variants, formulations and uses thereof

0

0

US Patent 12060590 PH20 polypeptide variants, formulations and uses thereof

0

0

US Patent 12077791 PH20 polypeptide variants with a modification at position 309 of the PH20 polypeptide and a method of making thereof

0

...

Patent Primary Examiner

0

Patent abstract

Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations and uses thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9447401 PH20 polypeptide variants, formulations and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool